Pharmacokinetics and pharmacodynamics of ticagrelor in patients with stable coronary artery disease: results from the onset-offset and respond studies
Clinical Pharmacokinetics,  Clinical Article

Husted SE et al. – Ticagrelor pharmacokinetics in stable coronary artery disease (CAD) patients were comparable to previous findings in stable atherosclerotic and acute coronary syndromes (ACS) patients, and were not affected by prior clopidogrel exposure or clopidogrel responsiveness. Ticagrelor effectively inhibited platelet aggregation, and trough plasma concentrations of ticagrelor and AR–C124910XX were sufficient to result in high IPA in stable CAD patients.

Methods
  • Patients were treated with ticagrelor (180mg loading dose, 90mg twice daily maintenance dose) or clopidogrel (600mg loading dose, 75mg once daily maintenance dose) in addition to aspirin (acetylsalicylic acid) [75–100mg once daily].
  • Ticagrelor administration was for 6 weeks in ONSET–OFFSET.
  • In RESPOND, ticagrelor was given for 14 days before or after 2 weeks of clopidogrel in patients classified as clopidogrel responders or non–responders.
  • Pharmacokinetics and IPA were evaluated following the loading and last maintenance doses.
  • Exposure–IPA relationships were evaluated using a sigmoid maximum effect (Emax) model.
  • The outcome measures were ticagrelor and AR–C124910XX (active metabolite) pharmacokinetics and exposure–IPA relationships in both trials, including the effect of prior clopidogrel exposure, and effects in clopidogrel responders and non–responders in RESPOND.

Results
  • In ONSET–OFFSET, maximum (peak) plasma concentration (Cmax), time to Cmax (tmax) and area under the plasma concentration–time curve from time 0 to 8 hours (AUC8) for ticagrelor were 733ng/mL, 2.0 hours and 4130ng•h/mL, respectively; and for AR–C124910XX were 210ng/mL, 2.1 hours and 1325ng•h/mL, respectively.
  • Emax estimates were IPA >97%.
  • Trough plasma ticagrelor (305ng/mL) and AR–C124910XX (121ng/mL) concentrations were 5.2 and 7.7 times higher than respective concentration producing 50% of maximum effect (EC50) estimates.
  • In RESPOND, ticagrelor mean Cmax and AUC8 following 2–week dosing were comparable between clopidogrel responders (724ng/mL and 3983ng•h/mL, respectively) and non–responders (764ng/mL and 3986ng•h/mL, respectively).
  • Pharmacokinetics of ticagrelor were unaffected by prior clopidogrel dosing.
  • Emax estimates were IPA >96% for both responders and non–responders.
  • Trough plasma concentrations were sufficient to achieve high IPA.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Nursing

See All >> Messages include industry-sponsored communications and special communications from MDLinx

<

Most Popular Nursing Articles

1 Vitamin D and sleep disorders Full Text Nature and Science of Sleep, August 13, 2014    Free full text    Clinical Article

2 Study identifies best way to treat neck pain Johns Hopkins Medicine, October 24, 2014

3 Metformin in chronic kidney disease: Time for a rethink Peritoneal Dialysis International, July 9, 2014    Clinical Article

4 Suffering from constipation? Self-acupressure can help UCLA Health System, November 19, 2014

5 Long-term associations of nut consumption with body weight and obesity American Journal of Clinical Nutrition, June 23, 2014    Clinical Article

6 Yogurt consumption, weight change and risk of overweight/obesity: The SUN cohort study Nutrition, Metabolism & Cardiovascular Diseases, July 28, 2014    Clinical Article

7 Coffee intake and gastric cancer risk Cancer Epidemiology, Biomarkers & Prevention, March 19, 2014    Clinical Article

8 Decreased ability to identify odors can predict death The University of Chicago Medical Center News, October 3, 2014

9 Yogurt and weight management American Journal of Clinical Nutrition, April 3, 2014    Review Article

10 UAB plans clinical trial for repurposed drug shown to reverse diabetes UAB Medicine, November 12, 2014

11 Effect of ginger (Zingiber officinale) on heavy menstrual bleeding: a placebo-controlled, randomized clinical trial Phytotherapy Research, October 13, 2014    Clinical Article

12 Impact of a 6-wk olive oil supplementation in healthy adults on urinary proteomic biomarkers of coronary artery disease, chronic kidney disease, and diabetes (types 1 and 2): a randomized, parallel, controlled, double-blind study American Journal of Clinical Nutrition, December 1, 2014    Evidence Based Medicine    Clinical Article

13 Associations of sugar and artificially sweetened soda and chronic kidney disease: A systematic review and meta-analysis Nephrology, September 24, 2014    Evidence Based Medicine    Review Article

14 Tea consumption and leukemia risk: A meta-analysis Tumor Biology, February 12, 2014    Evidence Based Medicine    Clinical Article

15 Vitamin D and melanoma and non-melanoma skin cancer risk and prognosis: A comprehensive review and meta-analysis European Journal of Cancer, August 7, 2014    Review Article

16 Dairy products, calcium, and prostate cancer risk: A systematic review and meta-analysis of cohort studies American Journal of Clinical Nutrition, November 26, 2014    Clinical Article

17 Association of tea consumption and the risk of oral cancer: A meta-analysis Oral Oncology , January 10, 2014    Evidence Based Medicine

18 Consumption of nuts and legumes and risk of incident ischemic heart disease, stroke, and diabetes: a systematic review and meta-analysis American Journal of Clinical Nutrition, June 19, 2014    Evidence Based Medicine    Review Article

19 Comparative efficacy of bisphosphonates in metastatic breast and prostate cancer and multiple myeloma: A mixed-treatment meta-analysis Full Text Clinical Cancer Research, November 27, 2013    Free full text    Evidence Based Medicine    Clinical Article

20 Chocolate consumption and risk of diabetes mellitus in the Physicians’ Health Study American Journal of Clinical Nutrition, December 10, 2014    Review Article

Indexed Journals in Nursing: Journal of Advanced Nursing, Journal of Clinical Nursing, Nurse Education In Practicemore

Make smarter career moves with less time.

Sign up for our free job placement service today and have a dedicated career consultant help locate the right physician job for you!
Click Here for more information.

Get Started Now!

Free-of-charge, no obligation.

Terms and Conditions For M3 Career Consult

By registering with the M3 Career Consult service you authorize M3 USA Corporation to represent you in your job search. The following is a summary of the terms of our service and our mutual obligations to help you find a job:

  • You designate M3 to act as your agent and represent you in your job search;
  • You will not pay us for this service
  • You will advise us of any companies or positions to which you apply or have applied;
  • You will advise us if you believe you are not capable of performing a position for which we submit you, or for which you interview;
  • You will keep all information we provide you about companies or positions strictly confidential;
  • You will promptly provide us with information we request of you;
  • You will make yourself reasonably available for phone, video and in-person conversations and interviews;
  • You will be truthful in all of your communications with us; and
  • You will advise us if anything above changes.
 

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List